Connective tissue diseases (CTDs) are a group of disorders characterized by abnormal immune system activity affecting the connective tissues throughout the body. These tissues include tendons, ligaments, skin, joints, and organs. Common CTDs include rheumatoid arthritis, systemic lupus erythematosus, and scleroderma. In CTDs, the immune system mistakenly attacks healthy tissues, leading to inflammation and tissue damage. Symptoms vary widely and may involve joint pain, skin rashes, fatigue, and internal organ complications. Treatment aims to manage symptoms and control inflammation, typically utilizing medications such as corticosteroids, disease-modifying antirheumatic drugs (DMARDs), and immunosuppressants. Multidisciplinary care involving rheumatologists, dermatologists, and other specialists is crucial for comprehensive management. Early detection and intervention play a key role in improving outcomes and enhancing the quality of life for individuals affected by connective tissue diseases.
Title : The tomographic phenotype and the genotype of wormian bones
Ali Al Kaissi, National Ilizarov Medical Research Center for Traumatology and Orthopaedics, Russian Federation
Title : Why rehabilitation following Total Joint Arthroplasty (TJA) should include a gait kinematic assessment and gait retraining
Diana Hodgins, Dynamic Metrics Ltd, United Kingdom
Title : Is my non-operative practice ok? – An audit tool for surgical patients
Chris Wainwright, Mater Private Hospital Mackay, Australia
Title : Is pregnancy a major risk factor for musculoskeletal pain: A cross-sectional study
Youssef Masharawi, Tel Aviv University, Israel
Title : Acute traumatic spinal injuries - Outcomes based evidence of the holistic active physiological conservative management of the injury and its neurological effects
Wagih El Masri, Keele University, United Kingdom
Title : The shape evolution of the human thoracic cage from birth to adulthood: Characterization and acceleration
Youssef Masharawi, Tel Aviv University, Israel